Evidence map›Paper›PMID 32329605›Full record

ReviewACS infectious diseases2020

Lactoferrin: A Critical Mediator of Both Host Immune Response and Antimicrobial Activity in Response to Streptococcal Infections.

Jacky Lu, Jamisha Francis, Ryan S Doster, Kathryn P Haley, Kelly M Craft, Rebecca E Moore, Schuyler A Chambers, David M Aronoff, Kevin Osteen, Steven M Damo and 3 more

Open access · greenAbstract readReview
In one paragraph

Review in ACS infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Positive Role of Saliva in the Oral Microbiome.Advances in experimental medicine and biology · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Jacky LuDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
Jamisha FrancisDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
Ryan S DosterDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
Kathryn P HaleyDepartment of Biomedical Sciences, Grand Valley State University, Allendale, Michigan 49401, United States.
Kelly M CraftDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37232, United States.ORCID 0000-0001-9753-2801
Rebecca E MooreDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37232, United States.
Schuyler A ChambersDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37232, United States.ORCID 0000-0002-3557-830X
David M AronoffDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.ORCID 0000-0003-4587-6121
Kevin OsteenDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
Steven M DamoDepartment of Chemistry, Fisk University, Nashville, Tennessee 37208, United States.
Shannon ManningDepartment of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan 48824, United States.
Steven D TownsendDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37232, United States.ORCID 0000-0001-5362-7235
Jennifer A GaddyDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.ORCID 0000-0002-2192-4224
Vanderbilt University · USVanderbilt University Medical Center · USVA Tennessee Valley Healthcare System · USGrand Valley State University · USMichigan State University · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Training In Cardiovascular ResearchT32HL007411 · NHLBI · VANDERBILT UNIVERSITY · PI BECKMAN, JOSHUA A · 1985 to 2020
$7.2M
Repurposing misoprostol to prevent recurrence of Clostridium difficile infectionU01TR002398 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DOSTER, RYAN S, DUBBERKE, ERIK R · 2018 to 2019
$3.1M
Bioorganic Approaches Toward Novel Antimicrobial Agents and ChemotherapeuticsR35GM133602 · NIGMS · VANDERBILT UNIVERSITY · PI Steven D. Townsend · 2019 to 2026
$3.0M
Determining the contribution of zinc deficiency to perinatal Group B Streptococcus infectionsR01HD090061 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ARONOFF, DAVID M, GADDY, JENNIFER A · 2017 to 2021
$2.5M
The Role of macrophages in chorioamnionitis and group B streptococcal infectionsR01AI134036 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ARONOFF, DAVID M · 2017 to 2021
$2.4M
STRUCTURE/FUNCTION ANALYSIS OF ENZYMESR01GM055513 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI HOLDEN, HAZEL · 1997 to 2004
$1.4M
Defining the impact of zinc on Streptococcus agalactiae biofilm and colonizationK08AI151100 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DOSTER, RYAN S · 2020 to 2024
$927k
Regulation of Helicobacter pylori pili encoded by the cag pathogenicity islandIK2BX001701 · VA · VETERANS HEALTH ADMINISTRATION · PI GADDY, JENNIFER A · 2013 to 2017
–
BLRD VA IK2 BX001701NCATS NIH HHS U01 TR002398NCATS NIH HHS UL1 TR000445NCRR NIH HHS UL1 RR024975NHLBI NIH HHS T32 HL007411NIAID NIH HHS K08 AI151100NIAID NIH HHS R01 AI134036NICHD NIH HHS R01 HD090061NIDDK NIH HHS P30 DK058404NIGMS NIH HHS R35 GM133602
6 · The paper itself

Abstract

Streptococcal species are Gram-positive bacteria responsible for a variety of disease outcomes including pneumonia, meningitis, endocarditis, erysipelas, necrotizing fasciitis, periodontitis, skin and soft tissue infections, chorioamnionitis, premature rupture of membranes, preterm birth, and neonatal sepsis. In response to streptococcal infections, the host innate immune system deploys a repertoire of antimicrobial and immune modulating molecules. One important molecule that is produced in response to streptococcal infections is lactoferrin. Lactoferrin has antimicrobial properties including the ability to bind iron with high affinity and sequester this important nutrient from an invading pathogen. Additionally, lactoferrin has the capacity to alter the host inflammatory response and contribute to disease outcome. This Review presents the most recent published work that studies the interaction between the host innate immune protein lactoferrin and the invading pathogen,

Indexed as

Anti-Infective AgentsPremature BirthStreptococcal InfectionsFemaleHumansImmunityInfant, NewbornLactoferrinPregnancyAnti-Infective AgentsLactoferrinantimicrobialbacteriainfectioninfectious diseaseinnate immunityironlactoferrinnutritional immunitypathogenesisstreptococcusvirulence

Identifiers

PMID32329605
PMCPMC7354219
OpenAlexW3019376541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.